Incidence of hepatitis C virus infection among people living with HIV: An Egyptian cohort study
- PMID: 36479422
- PMCID: PMC9724027
- DOI: 10.4102/sajhivmed.v23i1.1442
Incidence of hepatitis C virus infection among people living with HIV: An Egyptian cohort study
Abstract
Background: Egypt used to have one of the highest hepatitis C virus (HCV) infection prevalence rates worldwide, with an estimated HCV prevalence of around 4.5% to 6.7%.
Objectives: To determine the HCV infection incidence rate amid Egyptian patients living with HIV.
Method: A total of 460 HIV-positive patients were recruited in a retrospective cohort study from Imbaba Fever Hospital, Cairo, between January 2016 and March 2019. The patients had a negative baseline and at least one other HCV antibody test. Hepatitis C virus antibody testing was done by antibody sandwich third-generation enzyme-linked immunosorbent assay. The hepatitis C virus infection incidence rate among HIV-infected patients was calculated using the person-time incidence rate.
Results: Two hundred and eighteen patients were finally included: 146 (31.7%) patients were excluded for having a positive baseline HCV Ab result and 96 patients were excluded for not having a follow-up HCV Ab test. Eighteen patients had HCV seroconversion (8.3%), achieving an incidence rate of 4.06 cases per 100 person-years (95% confidence interval: 3.87-4.24). Injection drug use (IDU) was the commonest risk factor among seroconverters, with an HCV incidence rate of 7.08 cases per 100 person-years. Injection drug use history was reported in 83.3% of the seroconverters and in only 47.2% of non-seroconverters; P = 0.005.
Conclusion: Egyptian HIV-infected patients show a high incidence rate of HCV infection especially among those who have a history of IDU. Accordingly, attention should be paid for prevention, screening and timely treatment of HCV in patients infected with HIV.
What this study adds: The demonstration of a high HCV infection incidence rate among HIV-infected patients and shows the need for screening and prevention in this population.
Keywords: Egypt; HCV screening; HCV seroconversion; IDU; incidence rate of HCV; people living with HIV.
© 2022. The Authors.
Conflict of interest statement
G.E. is a speaker, advisory board member and investigator for Gilead Science. All other authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
Figures
Similar articles
-
Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials.Clin Infect Dis. 2011 Mar 15;52(6):812-8. doi: 10.1093/cid/ciq201. Epub 2011 Jan 31. Clin Infect Dis. 2011. PMID: 21282184 Free PMC article.
-
Incidence and risk factors of hepatitis C virus infection among human immunodeficiency virus (HIV) patients in a large HIV clinic in South Korea.Korean J Intern Med. 2016 Jul;31(4):772-8. doi: 10.3904/kjim.2015.353. Epub 2016 Apr 27. Korean J Intern Med. 2016. PMID: 27117318 Free PMC article.
-
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study.Clin Infect Dis. 2005 Aug 1;41(3):395-402. doi: 10.1086/431486. Epub 2005 Jun 21. Clin Infect Dis. 2005. PMID: 16007539
-
Current status of hepatitis C virus among people living with human immunodeficiency virus in Egypt.Trans R Soc Trop Med Hyg. 2022 Jun 1;116(6):571-578. doi: 10.1093/trstmh/trab176. Trans R Soc Trop Med Hyg. 2022. PMID: 34850231
-
Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression.Lancet HIV. 2022 Jun;9(6):e414-e427. doi: 10.1016/S2352-3018(22)00077-7. Lancet HIV. 2022. PMID: 35659336
Cited by
-
Future Prospects, Approaches, and the Government's Role in the Development of a Hepatitis C Virus Vaccine.Pathogens. 2023 Dec 31;13(1):38. doi: 10.3390/pathogens13010038. Pathogens. 2023. PMID: 38251345 Free PMC article. Review.
-
Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2023 Jun;8(6):533-552. doi: 10.1016/S2468-1253(23)00018-3. Epub 2023 Mar 27. Lancet Gastroenterol Hepatol. 2023. PMID: 36996853 Free PMC article.
-
Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma.Adv Virol. 2025 Mar 24;2025:9927410. doi: 10.1155/av/9927410. eCollection 2025. Adv Virol. 2025. PMID: 40165825 Free PMC article. Review.
References
-
- World Health Organization . Hepatitis C: Fact sheet [homepage on the Internet]. [updated 2021 Jul; cited 2022 Mar 18]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-c
-
- UNAIDS . Global HIV & AIDS statistics – 2021 fact sheet [homepage on the Internet]. [cited 2022 Mar 18]. Available from: www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
-
- El-Zanaty and Associates . Egypt health issues survey 2015. Rockville, MD: Ministry of Health and Population, ICF International; 2015.
LinkOut - more resources
Full Text Sources